The Biology and Science of ITPR3 Pathogenic Variants
At a Glance
Immunodeficiency 133 results from pathogenic ITPR3 variants that disrupt calcium release inside cells, weakening T-cell activation. Diagnosis combines genetic testing with immune-cell analysis, while ectodermal features and peripheral neuropathy may also occur.
To understand Immunodeficiency 133, it helps to think of your child’s cells as a house with a complex electrical system. In this condition, the “wiring” that controls calcium—the cellular signal for “action”—is not working correctly. This disruption happens because of a pathogenic variant in the ITPR3 gene [1][2].
The Biology of Calcium Signaling
This is a simplified model of how calcium signaling works. Calcium is not just for bones; inside a cell, it acts like a messenger. When the immune system detects a germ, it needs to send a signal to start fighting.
- The Trigger: A T-cell (a type of white blood cell) encounters a germ and sends a signal to the endoplasmic reticulum (ER), which is like a storage tank for calcium [3].
- The Gate: The ITPR3 gene provides the instructions for a “gate” called IP3R3 on that tank. Normally, the gate opens to let calcium into the rest of the cell [2][4].
- The Backup: When the tank starts to empty, it triggers another process called Store-Operated Calcium Entry (SOCE), which pulls in more calcium from outside the cell to keep the signal strong [2][3].
In children with this condition, the ITPR3 gate is altered. It may be “leaky,” causing the storage tank to stay empty, or it may simply refuse to open. This “blunted” calcium signal means the T-cells may not get the full message to activate, grow, or fight [1][2]. Because calcium is also needed for the development of hair, teeth, and nerves, these systems can be affected too, though the exact connection is still being studied [2][5].
How the Diagnosis is Confirmed
Diagnosing this ultra-rare condition requires specialized laboratory work. You should ensure you have copies of the following two types of reports:
1. The Genetic Report
This test looks at the ITPR3 gene itself. Your report should clearly state:
- Variant Type: The specific “spelling error” found (e.g., p.Arg2524Cys). The report will state if it is a pathogenic variant, a likely pathogenic variant, or a Variant of Uncertain Significance (VUS) [4].
- Zygosity: This tells you if the child has one altered copy (heterozygous), two identical altered copies (homozygous), or two different altered copies (compound-heterozygous). Many cases are de novo, meaning the variant happened for the first time in the child and was not inherited from the parents [2][4][1].
- Transcript Version: A code (like NM_002224.3) that helps doctors identify exactly which part of the gene is being discussed [4].
2. The Immunology Report (Flow Cytometry)
This test counts the different types of immune cells in the blood. In ITPR3 cases, doctors often see:
- T-cell Lymphopenia: A low total number of T-cells [2][4].
- Missing “Naïve” Cells: A very low number of “naïve” T-cells (cells that are ready to fight new germs) and a higher-than-normal percentage of “memory” cells (cells that have already fought something) [4].
- Functional Testing: Some highly specialized or research labs can perform a “calcium flux” test, where they watch in real-time to see if the cells respond correctly to a stimulus. However, this is not available or required for every patient [1][2].
Differentiating from Similar Conditions
Because ectodermal dysplasia (skin/teeth/hair issues) and immunodeficiency often go together, doctors must rule out other conditions that look similar:
| Condition | Primary Gene | Key Differences |
|---|---|---|
| Immunodeficiency 133 | ITPR3 | Often includes peripheral neuropathy (nerve weakness) and a specific T-cell “naïve vs. memory” imbalance [4][2]. |
| NEMO Deficiency | IKBKG | An X-linked condition affecting males and variably females; often includes a higher risk for specific “atypical” mycobacterial infections [1]. |
| ORAI1/STIM1 Deficiency | ORAI1 or STIM1 | Impairs the calcium entry (SOCE) and can cause combined immunodeficiency, often with distinct muscle weakness (myopathy) [2]. |
If your child’s genetic test was “negative” but they have these symptoms, a clinical geneticist may discuss Whole Exome Sequencing (WES) or Whole Genome Sequencing (WGS) based on clinical review [2][6].
Common questions in this guide
How do ITPR3 variants cause Immunodeficiency 133?
What genetic findings support a diagnosis of ITPR3-related Immunodeficiency 133?
What can flow cytometry show in Immunodeficiency 133?
Is a calcium flux test required to diagnose ITPR3-related disease?
How is Immunodeficiency 133 distinguished from similar conditions?
What happens if genetic testing does not find an ITPR3 variant?
Get notified when new evidence is published on immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (6)
- 1
Disrupted Ca2+ homeostasis and immunodeficiency in patients with functional IP3 receptor subtype 3 defects.
Neumann J, Van Nieuwenhove E, Terry LE, et al.
Cellular & molecular immunology 2023; (20(1)):11-25 doi:10.1038/s41423-022-00928-4.
PMID: 36302985 - 2
Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiency.
Blanco E, Camps C, Bahal S, et al.
The Journal of experimental medicine 2025; (222(1)) doi:10.1084/jem.20220979.
PMID: 39560673 - 3
A multiple-oscillator mechanism underlies antigen-induced Ca2+ oscillations in Jurkat T-cells.
Benson JC, Romito O, Abdelnaby AE, et al.
The Journal of biological chemistry 2023; (299(11)):105310 doi:10.1016/j.jbc.2023.105310.
PMID: 37778728 - 4
A pleiotropic recurrent dominant ITPR3 variant causes a complex multisystemic disease.
Molitor A, Lederle A, Radosavljevic M, et al.
Science advances 2024; (10(37)):eado5545 doi:10.1126/sciadv.ado5545.
PMID: 39270020 - 5
Missense mutations in inositol 1,4,5-trisphosphate receptor type 3 result in leaky Ca2+ channels and activation of store-operated Ca2+ entry.
Terry LE, Arige V, Neumann J, et al.
iScience 2022; (25(12)):105523 doi:10.1016/j.isci.2022.105523.
PMID: 36444295 - 6
[The Great Imposter: Three Cases of Inflammatory Bowel Disease Associated with Innate Immune Defects].
Hernández DPS, Tamayo SV
Acta gastroenterologica Latinoamericana 2026; (56(3)):357-364 doi:10.52787/agl.v56i3.597.
PMID: 42871851
This page explains ITPR3-related Immunodeficiency 133 and genetic and immune testing for informational purposes only and does not constitute medical advice. A clinical geneticist or immunologist should interpret your child’s results and discuss next steps.